GlassScriptPhysician profile
Amanda O Cameron
NPI 1194135558
$2,907.24
in general payments reported to CMS, 2019-2025
22 companies · $889 in 2025
The $889 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $338 · 2022: $322 · 2023: $739 · 2024: $619 · 2025: $889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,236 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,236.30 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $814.90 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Glaxosmithkline, LLC. | $336.83 | 2021-2025 | Jemperli, Zejula |
| Abbvie INC. | $333.28 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $259.77 | 2021-2025 | Lynparza |
| Myriad Genetic Laboratories, INC. | $200.65 | 2021-2024 | Mychoice Cdx |
| Seagen INC. | $114.75 | 2021-2023 | Tivdak |
| Immunogen, INC. | $112.55 | 2023 | Elahere |
| Eisai INC. | $112.04 | 2021-2025 | |
| Clovis Oncology, INC. | $106.64 | 2021-2022 | |
| Daiichi Sankyo INC. | $102.29 | 2025 | Enhertu |
| Tactile Systems Technology INC | $73.25 | 2023 | Entre Plus, Flexitouch Plus |
| Pfizer INC. | $48.66 | 2025 | |
| Tempus Ai, INC | $45.22 | 2024-2025 | Xt Cdx |
| Caris Mpi, INC. | $43.57 | 2025 | Mi Cancer Seek |
| Davol INC. | $39.13 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $29.85 | 2024 | Veozah |
| Genmab U.S., INC. | $27.55 | 2025 | |
| Incyte Corporation | $26.87 | 2025 | Monjuvi, Zynyz |
| Baxter Healthcare | $25.49 | 2024 | Perclot |
| Boston Scientific Corporation | $19.73 | 2024 | Spaceoar Vue System - 10ml |
| Foundation Medicine, INC. | $17.21 | 2022 | |
| Genentech USA, INC. | $17.01 | 2025 | Lunsumio, Columvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Cameron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.